AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 31 filers reported holding AXSOME THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,762,626 | +96.5% | 96,761 | +116.9% | 0.02% | +21.4% |
| Q4 2022 | $3,441,232 | -41.8% | 44,616 | -66.4% | 0.01% | -53.3% |
| Q3 2022 | $5,916,000 | +1743.0% | 132,593 | +1480.2% | 0.03% | +1400.0% |
| Q2 2022 | $321,000 | -9.3% | 8,391 | -21.8% | 0.00% | +100.0% |
| Q3 2021 | $354,000 | -76.1% | 10,730 | -51.2% | 0.00% | -83.3% |
| Q2 2021 | $1,484,000 | +109.3% | 22,003 | +75.6% | 0.01% | +50.0% |
| Q1 2021 | $709,000 | -33.9% | 12,529 | -31.3% | 0.00% | -85.2% |
| Q1 2020 | $1,073,000 | +0.8% | 18,234 | +77.1% | 0.03% | +350.0% |
| Q4 2019 | $1,064,000 | +9.6% | 10,297 | -72.7% | 0.01% | -33.3% |
| Q2 2019 | $971,000 | +451.7% | 37,706 | +20.1% | 0.01% | +200.0% |
| Q4 2017 | $176,000 | -5.4% | 31,400 | -6.5% | 0.00% | -25.0% |
| Q3 2017 | $186,000 | – | 33,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 785,683 | $60,599,730 | 58.10% |
| Fairmount Funds Management LLC | 2,011,647 | $155,158,333 | 24.61% |
| VR Adviser, LLC | 670,718 | $51,732,479 | 8.72% |
| Ghost Tree Capital, LLC | 235,000 | $18,126,000 | 7.74% |
| SVB FINANCIAL GROUP | 33,849 | $2,610,773 | 7.14% |
| Tri Locum Partners LP | 200,054 | $15,430,000 | 6.24% |
| BVF INC/IL | 1,755,000 | $135,363,150 | 5.71% |
| RTW INVESTMENTS, LP | 2,980,482 | $229,884,577 | 4.69% |
| TANG CAPITAL MANAGEMENT LLC | 320,000 | $24,681,600 | 3.59% |
| PFM Health Sciences, LP | 1,092,831 | $84,290,055 | 3.02% |